Table 3

One- and two-year survival ratesa

1-yr survival (%)χ2P2-yr survival (%)χ2P
Disease extent
 Limited5220
 Extensive343.120.0892.360.12
Sex
 Male4012
 Female551.490.22200.880.38
Performance score
 05216
 1–3304.420.04110.510.47
topo IIα
 <30%5318
 30–60%5015
 >60%236.180.04681.300.52
topo IIβ
 <30%4614
 30–60%4319
 >60%400.260.88110.620.73
Ki67
 <30%6832
 30–60%3812
 >30%365.860.05307.210.027
p53
 ≤10%4215
 >10%440.070.79130.030.86
p21
 ≤10%4314
 >10%410.030.8790.390.53
bcl-2
 ≤10%4530
 >10%420.050.83105.170.023
MRP
 ≤10%3510
 >10%460.820.37160.440.51
  • a All patients were followed for at least 2 years. All Ps are two-sided and were considered statistically significant at <0.05.